Deepak Sabharwal and Iana Malasevskaia 2026. Role of PCSK9 Inhibitors in Contemporary Lipid-Lowering Era: A Systematic Review of LDL-C Reduction, Cardiovascular Outcomes, and Use in Statin-Intolerant and Very-High-Risk Patients. Journal For International Medical Graduates. 5, 1 (Apr. 2026). DOI:https://doi.org/10.56570/hkdzy418.